Dr. ChristianPaul

Partner

ミュンヘン + 49.89.20.60.42.200 デュッセルドルフ + 49.211.5406.5500

Connect:

共有

Dr. Christian Paul represents clients in patent litigation and complex technology-related litigation. Christian combines a rare double qualification as an attorney and natural scientist — he graduated in computational chemistry on the use of artificial intelligence in drug discovery and has training in the fields of technical chemistry, organic chemistry, and biochemistry. His practice focuses on the resolution of disputes over chemical, pharmaceutical, and biotechnological patents, software, computer technology, and industrial high-tech applications.

For more than 20 years, Christian has served as trial counsel for international clients in litigation involving a wide range of patents, including biotechnology and pharmaceutical products, diagnostics, polymers, and chemical products, as well as complex software and technology-related litigation including misappropriation of trade secrets and cross-border discovery. Further to his doctorate degree in law, Christian is qualified as a German certified IP expert (Fachanwalt für Gewerblichen Rechtsschutz).

Christian is the author of a number of articles on software/informatics, medical science/pharmacology, and intellectual property law. He is a member of the German Association for the Protection of Intellectual Property (GRUR), the Licensing Executives Society (LES), the Association of Intellectual Property Experts (VPP), and the Munich Dispute Resolution Forum (IDPR).

担当案件

  • CJ CheilJedang defends German patent infringement action by Japanese competitorJones Day represented CJ CheilJedang Corporation, a major Korean-based multinational company, in an international patent dispute with a Japanese competitor before the courts in Germany, including the Federal Supreme Court of Germany.
  • Idenix enforces patent against Gilead in Germany over sofosbuvirJones Day represented Idenix Pharmaceuticals LLC (a subsidiary of Merck & Co., Inc.) in patent litigation against Gilead in Landgericht Düsseldorf in Germany over sofosbuvir, the active ingredient in Sovaldi® and Harvoni®, Gilead's blockbuster drugs for treating Hepatitis C.
  • Idenix defends nucleoside analogue patent in EPO opposition against five opponentsJones Day represented Idenix Pharmaceuticals LLC (a subsidiary of Merck & Co., Inc.) in opposition proceedings before the EPO related to Idenix patent covering nucleoside analogs and prodrugs.
  • Idenix asserts patent infringement against Gilead in France related to Sovaldi® and Harvoni®Jones Day represents Idenix Pharmaceuticals LLC (a subsidiary of Merck & Co., Inc.) in patent litigation against Gilead in Tribunal de Grande Instance de Paris in France over sofosbuvir, the active ingredient in Sovaldi® and Harvoni®, Gilead's blockbuster drugs for treating Hepatitis C.
  • Global manufacturer of specialty adhesives enforces hotmelt adhesive patent against major German competitorJones Day represents a manufacturer of specialty adhesives in patent litigation against a major German competitor before the courts in Düsseldorf and the German Federal Patent Court.
  • Mount Sinai School of Medicine enforces patent on key biotech pharmaceutical productJones Day represented Mount Sinai School of Medicine of New York University in a multinational cross-jurisdictional patent infringement litigation against a global pharmaceutical company.
  • Major Japanese chemical company engages in multijurisdiction patent disputeJones Day advises a major Japanese producer of specialty chemicals in a multijurisdictional patent dispute in Europe, including representation before the courts in France and Germany.
  • Global diagnostics manufacturer defends market position in patent infringement dispute over test kit for tissue transglutaminaseJones Day represents an international manufacturer of medical laboratory diagnostics in a multi-jurisdiction patent infringement dispute over a test kit for tissue transglutaminase.
  • Leading American manufacturer conducts dawn raid against German competitorJones Day represents a leading U.S. cigarette paper manufacturer in enforcing its patent rights in Germany.
  • Global pharmaceutical company defends against patent infringement allegationsJones Day represented and defended a global pharmaceutical company in relation to patent infringement proceedings in Italy and in Germany.
  • Stopaq asserts in Germany several patents against competitor involving self-healing, anti-corrosion preparations for use on oil and gas pipelinesJones Day is advising Stopaq B.V., a Netherlands-based manufacturer of corrosion protective coatings and sealants, in a multi-patent litigation against a major competitor.
  • German high-tech company seeks trade secrets counseling after new hireJones Day advises a German high-tech client in a case of alleged misappropriation of trade secrets after hiring a key employee of a competitor.
  • Swedish manufacturer of food supplements enforces patents against infringer in GermanyJones Day represents a Swedish manufacturer for food supplements in a patent infringement litigation against an infringer in Germany.
  • Global diagnostics manufacturer defends against patent infringement charges over test kit for detecting paraneoplastic syndromeJones Day represents an international manufacturer of medical laboratory diagnostics in a patent litigation relating to a test kit for detecting paraneoplastic syndrome.
  • U.S.-based global supplier of metal semifinished products seeks counseling regarding trade secret misappropriationJones Day advises a U.S.-based global supplier of metal semifinished products on a case of potential trade secret misappropriation.
  • Global diagnostics manufacturer challenges patent for a test kit for detecting tissue transglutaminaseJones Day is representing an international manufacturer of medical laboratory diagnostics in a nullity action against the German part of a European patent relating to a test kit for tissue transglutaminase.
  • Stopaq develops patent portfolio relating to self-healing, anti-corrosion coatings and sealants for use on oil and gas pipelinesJones Day is advising Netherlands-based Stopaq B.V. in prosecuting its patent portfolio relating to a novel anti-corrosion protection for oil and gas pipelines that provides self-healing capability.
  • Global hydraulic press manufacturer conducts dawn raids in trade secrets dispute against newly-founded company of former employeesJones Day represented an international client in a trade secrets litigation against a newly emerging company founded by former employees.
  • Leading sealing slide manufacturer defends against patent infringement charges in multi-jurisdiction dispute involving manufacturing processJones Day represents a leading international manufacturer of sealing slide fasteners in a multi-jurisdiction patent litigation against a European competitor involving polymer chemistry, specifically injection-moulding processes and adhesion reactions during overmoulding.
  • Inventor-founded charitable trust asserts its patent rights and seeks royalties over diagnostic and therapeutic agent for treatment of autoimmune hepatitisJones Day assisted an inventor-founded charitable trust in enforcing its patents to collect royalties.
  • French manufacturer of glass inspection devices defends against patent infringement charges brought by Netherlands-based plaintiffJones Day represents a French market leader for glass inspection devices in series of patent infringement actions in Germany against a Netherlands-based Plaintiff involving a technology for hot-end hollow glass inspection devices.
  • U.S. therapeutics company uses European corporate intelligence for patent opposition proceedingsJones Day provided strategic advice to a U.S. therapeutics company for defending a key patent in European opposition proceedings.
  • Glass inspection device manufacturer successfully defends against alleged patent infringement at seizure at a German trade fairJones Day represents a leading French manufacturer of glass inspection devices in a series of patent infringement actions in Germany against a Netherlands-based Plaintiff.
  • French manufacturer of glass inspection devices pursues dawn raid against suspected patent infringerJones Day represents patentee in a dawn raid against a competitor to inspect competitor's manufacturing facilities.
    •

    December 2024 Commentary

    Unified Patent Court: First Ruling on Equivalent Infringement

    November 2024 Commentary

    UPC: Patentees No Longer Locked Out by Pre-Transitional Period National Litigations

    November 2024 Commentary

    The Unified Patent Court: Also an Attractive Jurisdiction for SMEs

    November 2024 Commentary

    Germany's Legal Privilege: What In-House Counsel Need to Know

    October 2024 Commentary

    A Rollback on Referral to the EBA Regarding Adaptation of Description

    August 2024 Alert

    Epitope Claims Live On at the European Patent Office

    July 2024 Commentary

    Prior Art and Public Availability: Key Decisions in German Patent Litigation

    July 2024 Commentary

    EU Parliament Adopts SPC Reform Proposals: Clarifying the Protection Scope for Biologics

    March 2024 Alert

    Finish in Eight Months: The EPO Sets Timeline for New Accelerated Opposition Practice

    March 2024 Alert

    Unified Patent Court Publishes Its First Case Load Statistics
    インサイト一覧

    • September 26, 2023
      UPC Mock Trial Presiding Judge. Half-day pre-conference workshop at the C5 Life Sciences IP Summit
    • May 22, 2023
      State of affairs at the patent litigation chambers in Munich: Experience exchange between Munich judges and patent practicioners
    • September 21, 2021
      A Shifting Landscape for Patent Litigation in Europe
    • September 3, 2020
      European Trade Secrets Webinar: Combating New Threats Webinar
    • November 21, 2019
      New Supreme Court decisions and their impact on patent practice (co-presentation with Prof. Meier-Beck, presiding judge of the patent senate at the German Federal Supreme Court)
    • October 27, 2016
      Cross-border IP litigation in the US and Europe: Strategic options for validity and infringement, VPP half-day seminar
    • April 29, 2013
      Europe's New Unitary Patent and Unified Patent Court: How It Will Work, and What Will Change In European Patent Litigation
    • Nov 13, 2012
      Key Strategies for European Patent Litigation
    • October 11, 2011
      Developing a Patent Litigation Strategy for Europe
    • May 14, 2011
      International Patent Litigation - A Focus on Transatlantic Litigation Strategies
    • March 16, 2010
      Drafting Successful Patent Applications for Biotechnology Related Inventions, Litigation Issues, Pre-Conference Workshop
    • February 18, 2010
      Patenting Pharmaceutical and Biotech Products in China - Effects of the 3rd Amendment to the Patent Act, Biotech and Pharmaceutical Patenting
    • October 22, 2009
      Global Enforcement of Patent Rights - Focus on China
    • June 18, 2009
      Drafting Successful Patent Applications for Biotechnology Related Inventions - Litigation Issues, Post-Conference Workshop
    • March 13, 2009
      Patenting Pharmaceuticals and Strategic Options for Optimization

    送信する前の注意事項：

    www.jonesday.comに掲載されている情報は、一般的な使用を目的としており、法的アドバイスを目的としたものではありません。このEmailを送信することにより、弁護士を含む専門家・依頼者の関係を構築することを意図するものではなく、このEmailの受領はそのような関係を構築するものではありません。当事務所に送信されたいかなる情報も、業務委託契約を結ばない限り、弁護士等が依頼者に対して守秘義務を負う機密事項として取り扱われることはありません。このEmailの送信者は以上の注意事項の内容を読み、理解したものと判断します。